Hudson Bay Capital Management »

Summit Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $200k 11k 17.49
2024-06-30 $585k 75k 7.80

More positions owned by Hudson Bay Capital Management

Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Palantir Technologies Cl A Put Option (PLTR)
Microsoft Corporation Call Option (MSFT)
Netflix Put Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Flagstar Bank National Assoc Com New (FLG)
Dollar Tree Call Option (DLTR)
Boeing Company Call Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Susquehanna International
Geode Capital Management
Citadel Advisors
Pictet Asset Management Holding SA
Norges Bank Investment Management
Apeiron Capital
Nomura Holdings
TD Asset Management
Standard Life Aberdeen
Charles Schwab Investment Management

View all funds holding Summit Therapeutics